Arcadia Biosciences Inc. (RKDA)
$0.50
$-0.02
(-2.97%)
As on 01-Sep-2026 16:17EDT
Market cap
$1 Mln
Revenue (TTM)
$5 Mln
P/E Ratio
--
P/B Ratio
2
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
-4.3 %
-
ROCE
-- %
-
Industry P/E
37.67
-
EV/EBITDA
0.6
-
Debt to Equity
0
-
Book Value
$--
-
EPS
$-8.1
-
Face value
--
-
Shares outstanding
2,409,211
10 Years Aggregate
CFO
$-177.10 Mln
EBITDA
$-179.37 Mln
Net Profit
$-165.73 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Arcadia Biosciences (RKDA)
| -74.6 | -19.4 | -47.8 | -86.9 | -47.6 | -65.1 | -55.7 |
|
BSE Sensex*
| -9.6 | -2.0 | 3.1 | -4.7 | 5.4 | 6.0 | 10.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Arcadia Biosciences (RKDA)
| -66.6 | 88.2 | -71.1 | -73.9 | -58.9 | -53.8 | 72.9 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Arcadia Biosciences (RKDA)
|
0.5 | 1.3 | 4.8 | -11.1 | -102.3 | -466.4 | -- | 2.0 |
| 75.6 | 3,334.7 | 1,843.0 | 52.0 | 10.3 | 2.8 | 46.4 | 1.8 | |
| 15.1 | 2,361.3 | 5,797.0 | -304.0 | -7.0 | -- | -- | 12.5 | |
| 24.4 | 1,033.6 | 1,292.1 | 18.4 | 8.5 | 7 | 61.6 | 4.1 | |
| 130.1 | 1,315.8 | 676.9 | 160.2 | 28.3 | 52.3 | 8.1 | 3.7 | |
| 10.1 | 1,129.7 | 869.3 | -61.3 | 9.1 | -10.3 | 44.9 | 1.9 | |
| 11.9 | 1,380.0 | 3,251.2 | -2,758.0 | -19.7 | -148.8 | 11.5 | 0.8 | |
| 124.6 | 2,512.3 | 1,106.1 | 80.6 | 10.9 | 15.1 | 30.5 | 4.5 | |
| 9.4 | 1,781.9 | 5,898.0 | -171.0 | -0.3 | -8.2 | -- | 0.7 | |
| 59.1 | 3,552.0 | 3,373.4 | 74.0 | 10.4 | -- | 23.6 | 21.9 |
Shareholding Pattern
View DetailsAbout Arcadia Biosciences (RKDA)
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as... well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas. Read more
-
President, CEO & Director
Mr. Stanley E. Jacot Jr.
-
President, CEO & Director
Mr. Stanley E. Jacot Jr.
-
Headquarters
Dallas, TX
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Arcadia Biosciences (RKDA)
What is the current share price of Arcadia Biosciences Inc (RKDA) Today?
The share price of Arcadia Biosciences Inc (RKDA) is $0.50 (NASDAQ) as of 01-Sep-2026 16:17 EDT. Arcadia Biosciences Inc (RKDA) has given a return of -47.6% in the last 3 years.
What is the current PB & PE ratio of Arcadia Biosciences Inc (RKDA)?
Since, TTM earnings of Arcadia Biosciences Inc (RKDA) is negative, P/E ratio is not available.
The P/B ratio of Arcadia Biosciences Inc (RKDA) is 1.95 times as on 28-Aug-2026, a 4 discount to its peers’ median range of 2.03 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-1.16 |
0.65 |
2024 |
-1.15 |
1.30 |
2023 |
-0.29 |
0.31 |
2022 |
-0.01 |
0.01 |
2021 |
-0.04 |
0.02 |
What is the 52 Week High and Low of Arcadia Biosciences Inc (RKDA)?
The 52-week high and low of Arcadia Biosciences Inc (RKDA) are Rs 6.71 and Rs 0.38 as of 02-Sep-2026.
What is the market cap of Arcadia Biosciences Inc (RKDA)?
Arcadia Biosciences Inc (RKDA) has a market capitalisation of $ 1 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Arcadia Biosciences Inc (RKDA)?
Before investing in Arcadia Biosciences Inc (RKDA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.